Fig 4C demonstrates a 58kDa PKM2 protein band in the immunoblot in which the cytoplasmic PKM2 protein was decreasing in a concentration dependent manner upon treatment with SMI or shRNA-PKM2 NSCLC cell lines. This evidence concerns the gene PKM and non-small cell lung carcinoma.